Home > Insider Trading > Filing (0001140361-13-034611)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
275053	Natures Sunshine Products Inc	NATR	Pharmaceutical Preparations (2834)	870327982

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1459276	Jamon Jarvis	75 East 1700 South Provo UT 84606	Evp, Gen Counsel, Sec, Cco	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-08-27	4,100	$9.87	4,100	No	4	M	Direct
Common Stock	Disposition	2013-08-27	4,100	$17.81	0	No	4	S	Direct
Common Stock	Acquisiton	2013-08-28	23	$9.87	23	No	4	M	Direct
Common Stock	Disposition	2013-08-28	23	$17.80	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2013-08-27	4,100	$0.00	4,100	$9.87
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2013-08-28	23	$0.00	23	$9.87

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
37,747		2021-01-03	No	4	M	Direct
37,724		2021-01-03	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.80 to $17.8981, inclusive. The reporting person undertakes to provide Nature's Sunshine Products, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
On August 8, 2013, the Issuer declared a one-time cash dividend of $1.50 per share to shareholders of record as of August 19, 2013, to be paid on August 29, 2013. As a result, pursuant to anti-dilution provisions of the Issuer's stock incentive plans, the exercise price of all outstanding options were reduced by $1.50.
On May 10, 2010, the reporting person was granted an option to purchase 42,000 shares of common stock. The option vests in three equal installments based on satisfaction of certain performance criteria. The performance criteria for two-thirds of the options were determined to have been met on 3/1/12, resulting in vesting of the option with respect to 28,000 shares. The remainder of the option vested with respect to 14,000 shares on 8/21/12 when the performance criteria for the final one-third of the options were determined to have been met.